13F-HR filed by MIC Capital Management UK LLP
MIC Capital Management UK LLP filed this 13F-HR for the quarter ended 2025-03-31, filed 2025-05-15, with 14 holding rows worth $490,823,688.
- Accession
- 0001085146-25-003296
- Filer
- CIK 1889830
- Filed
- 2025-05-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2025
A holdings report, 17 entries on the cover page, a total value of $490,823,688 stated on the cover page (in dollars after the unit check, H1), rows summing to $490,823,688 with VALUE read as dollars as filed, 13F file number 028-22102. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| HAYWARD HLDGS INC | 421298100 | COM | 9,997,545 | $139,165,826 | dollars as filed | |
| METSERA INC | 59267L107 | COM | 4,539,540 | $123,566,279 | dollars as filed | |
| RECURSION PHARMACEUTICALS IN | 75629V104 | CL A | 9,644,032 | $51,016,935 | dollars as filed | |
| COUPANG INC | 22266T109 | CL A | 1,412,946 | $30,985,906 | dollars as filed | |
| RESTAURANT BRANDS INTL INC COM | 76131D103 | Stock | 386,203 | $25,736,568 | dollars as filed | |
| GRABHLDGSLTDFCLASSCLASSA | G4124C109 | STOK | 5,000,000 | $22,650,000 | dollars as filed | |
| ALIBABA GROUP HLDG LTD | 01609W102 | SPONSORED ADS | 150,000 | $19,834,500 | dollars as filed | |
| META PLATFORMS INC CL A | 30303M102 | COM | 33,300 | $19,192,788 | dollars as filed | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 508,569 | $17,983,000 | dollars as filed | |
| MONDAY COM LTD SHS | M7S64H106 | Stock | 66,000 | $16,048,560 | dollars as filed | |
| SPORTRADAR GROUP AG | H8088L103 | COM | 660,000 | $14,269,200 | dollars as filed | |
| ARCHER AVIATION INC | 03945R102 | COM CL A | 700,000 | $4,977,000 | dollars as filed | |
| NEUMORA THERAPEUTICS INC. | 640979100 | COM | 4,460,700 | $4,460,700 | dollars as filed | |
| LYELL IMMUNOPHARMA INC | 55083R104 | COM | 1,740,569 | $936,426 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001085146-25-003296 | this filing | 2025-05-15 | acceptance time not in the bulk data set |